Image of the Day: 70 Years of Disease Research

A video chronicles the course of disease research and prompts questions about where scientists may focus their studies in the future.

Written byAmy Schleunes
| 1 min read
70 Years of Disease Research

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Helder Nakaya and his team at the University of Sao Paulo in Brazil used PubMed to analyze more than 29,000,000 articles on disease research over the past 70 years.

“Our goal was to verify if outbreaks could shift research,” says Nakaya in an email to The Scientist. “I expected to see Zika and Ebola among the most studied diseases right after the recent outbreaks but they did not reach the top 20 when all diseases were included.”

Some of the spikes in publication topics surprised Nakaya. “I had no idea that knowledge about HIV/AIDS advanced so quickly after 1985,” he writes. “[S]eeing the rise of ‘Obesity’ from the 2000s and ending at ‘second place’ in 2017 was also very interesting.”

Nakaya concludes that scientists are “publishing way too much and there is no time to read all papers about just one disease. Also, it is very hard to evaluate and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies